NEFL and peripheral nervous system disorder: Furthermore, they proved that serum NFL is correlated with disease activity and disability progression, subsequently extending the previous findings and suggesting a potential role for this biomarker in monitoring axonal damage and treatment efficiency in peripheral nervous system disorders (Mariotto et al., 2018).